6505--Acyclovir Capsules (VA-25-00048078)
ID: 36E79725R0033Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNAC PHARMACEUTICALS (36E797)HINES, IL, 60141, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)
Timeline
    Description

    The Department of Veterans Affairs is seeking offers for the procurement of Acyclovir Capsules under solicitation number 36E79725R0033, with the aim of establishing pricing and availability for these pharmaceutical supplies. Bidders are required to submit prices for both the base and option years, ensuring compliance with the Drug Supply Chain Security Act and maintaining acceptable FDA manufacturing status. This procurement is critical for providing necessary medications to veterans and military personnel, emphasizing the importance of timely delivery and adherence to inventory standards. The deadline for receipt of offers has been extended to May 20, 2025, at 2:30 PM CDT, and interested parties should contact Contract Specialist Nicholas I McGregor at Nicholas.McGregor@va.gov for further details.

    Point(s) of Contact
    Nicholas I McGregorContract Specialist
    Nicholas.McGregor@va.gov
    Files
    Title
    Posted
    The Presolicitation Notice from the Department of Veterans Affairs (VA) outlines a request for proposals (RFP) for Acyclovir Capsules, specifically soliciting bids for two line items related to the drug's supply. The document provides essential information regarding the solicitation number (36E79725R0033), response deadline (May 1, 2025), and details the quantity and packaging specifications for the capsules. Line Item 1 requires 3,256 bottles of Acyclovir 200MG capsules (100 capsules per bottle) for the base year and each of the four option years. Line Item 2 requests 15,475 bottles of Acyclovir 200MG capsules (500 capsules per bottle) under the same terms. Offerors must submit pricing for both items to be considered, ensuring their bids do not exceed two decimal places. The main purpose of this presolicitation notice is to inform potential suppliers about the upcoming procurement for the VA, emphasizing the required quantities and the submission process. This is instrumental for federal contracting, facilitating competition and compliance within the pharmaceutical supply chain specifically for veterans' healthcare needs.
    The document outlines the solicitation and contract process for pharmaceutical supplies under the Department of Veterans Affairs (VA) and Department of Defense (DoD) Pharmaceutical Prime Vendor (PPV) Programs. It specifies that the contract is intended to establish pricing and availability for Acyclovir capsules, with bidders required to submit prices for both the base and option years inclusive of a 0.5% Cost Recovery Fee. Key elements include the need for a unique National Drug Code (NDC) for each product, compliance with the Drug Supply Chain Security Act (DSCSA), and the requirement for offerors to have an acceptable FDA status for manufacturing facilities. The solicitation emphasizes the critical nature of timely delivery, noting consequences for failure to meet inventory or compliance standards, including contract termination. Additionally, it mandates that offerors must submit sales reports quarterly and adhere to specific labeling and packaging requirements. The contract will span an implementation period followed by a base year and four one-year options. This comprehensive process is designed to ensure the government can reliably procure pharmaceuticals while adhering to federal regulations and maintaining healthcare standards for veterans and military personnel.
    The document serves as an amendment to solicitation number 36E79725R0033 by the Department of Veterans Affairs, specifically the OPAL/National Acquisition Center. The primary purpose of this amendment is to extend the deadline for the receipt of offers from May 14, 2025, to May 20, 2025, at 2:30 PM CDT. This extension is communicated to all potential offerors and emphasizes that all other terms and conditions of the original solicitation remain unchanged. The amendment outlines the required acknowledgment methods for receipt of the amendment and highlights the importance of adhering to the extended deadline to avoid rejection of offers. The structure includes sections for pertinent identification details of the contract, amendment specifics, and instructions for the acknowledgment process, ensuring a clear and organized format for stakeholders involved in the proposal submission. This document reflects the government's procedural updates in the contract solicitation process, aiming to ensure effective communication and adequate time for bidders.
    Lifecycle
    Title
    Type
    Similar Opportunities
    6505--Zonisamide Capsules
    Buyer not available
    The Department of Veterans Affairs (VA) intends to issue a Request for Proposal (RFP) for the unrestricted procurement of Zonisamide Capsules, which will serve various federal entities including the Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The contract will be awarded to a single offeror capable of providing an uninterrupted supply of the specified medications, with a contract period of one year and four optional one-year extensions. The procurement is critical for ensuring the availability of these pharmaceutical products, which are essential for patient care within the VA and other federal health facilities. Interested parties should monitor SAM.gov for the solicitation, expected to be issued around December 15, 2025, with a closing date of December 30, 2025, and may direct inquiries to Chris Carthron at Christopher.Carthron@va.gov.
    VISN 21 Lenalidomide Capsules Multiple Strengths (Generic)
    Buyer not available
    The Department of Veterans Affairs (VA) is conducting a Sources Sought notice to identify vendors capable of supplying Lenalidomide Capsules in multiple strengths, specifically for VISN 21, which includes locations in California, Hawaii, Nevada, and Manila, Philippines. The contractor must be a Certified Lenalidomide REMS Pharmacy, licensed in the applicable states, and comply with all relevant federal, state, and VA regulations, including USP <800> for hazardous drugs. This procurement is critical as Lenalidomide is an oral anti-cancer medication, and the contract will span five one-year ordering periods from March 1, 2026, to February 28, 2031, requiring timely and compliant delivery of FDA-approved products. Interested vendors should submit their capability statements and relevant information to David J. Alvarez at david.alvarez4@va.gov by 10:00 AM Pacific Time on December 10, 2025.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    Dimethyl Fumarate DR Presolicitation
    Buyer not available
    The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Dimethyl Fumarate DR capsules, specifically 120MG capsules in 14 count bottles and 240MG capsules in 60 count bottles. This procurement aims to establish a reliable national supply source for these pharmaceutical products, which are essential for Department of Defense (DoD) customers through the DLA prime vendor program. The contract will be a firm-fixed price, requirements type contract with a one-year base period and four one-year options, emphasizing compliance with federal regulations and efficient distribution of pharmaceuticals for military healthcare. Interested parties should contact Kevin Rafferty at kevin.rafferty@dla.mil or 215-737-0907 for further inquiries, and the projected solicitation date is February 2021, with an amendment extending the offer submission deadline to October 14, 2021, at 3:00 PM EST.
    6505--Biologics by McKesson Specialty Pharmacy (Lenalidomide) (VA-26-00016920)
    Buyer not available
    The Department of Veterans Affairs is seeking qualified suppliers to provide Lenalidomide, a pharmaceutical product, for the Oscar G. Johnson VA Medical Center located in Iron Mountain, MI. This procurement will be conducted through a Brand Name or Equal Request for Quotation (RFQ) under firm-fixed price terms, following FAR Part 13 Simplified Acquisition Procedures. Lenalidomide is crucial for treating certain conditions, making this procurement significant for patient care within the VA system. Interested offerors must submit an itemized quote along with sufficient technical documentation via email to arneil.genus@va.gov by 3 p.m. Central on December 1, 2025, as telephone inquiries will not be accepted.
    DA01--550-26-1-985-0034 InstyMed Dispenser System (VA-26-00024776)
    Buyer not available
    The Department of Veterans Affairs (VA) intends to negotiate a limited source contract for the InstyMed Dispenser System, identified by Solicitation Number 36C25226Q0106. This procurement includes the purchase of the dispenser system and professional installation services, emphasizing that it is not a request for proposal or quote, as no solicitation document is available. The InstyMed Dispenser System is crucial for enhancing medication delivery and management within VA facilities. Interested parties must respond to this notice by December 12, 2025, at 10:00 am CST, and can contact Contracting Officer Vernise L. Newton at vernise.newton@va.gov or by phone at 414-844-4850 for further information.
    Q517--36C249-26-AP-0130 - VISN - Annual Wall-to-Wall Pharmacy Inventory
    Buyer not available
    The Department of Veterans Affairs, through the Network Contracting Office 9, is seeking proposals for Annual Wall-to-Wall Pharmacy Inventory services across various VA Medical Centers within VISN 09. The procurement aims to secure contractor support for the physical counting of both controlled and non-controlled pharmacy drugs, ensuring reconciliation with automated systems and compliance with VA, DEA, and FDA regulations. This service is critical for maintaining accurate inventory records and ensuring the proper management of pharmaceutical supplies within the VA healthcare system. Interested parties, particularly Service-Disabled Veteran-Owned Small Business Concerns (SDVOSBC), should note that the solicitation is anticipated to be issued on December 8, 2025, with responses due by December 15, 2025, and the contract award expected on December 17, 2025. For further inquiries, contact Mario Russell at mario.russell@va.gov.
    InstyMed Dispenser System
    Buyer not available
    The Department of Veterans Affairs is issuing a modification to its previous notice regarding the InstyMed Dispenser System, indicating its intent to negotiate a limited source contract. This modification serves to establish a deadline for responses, emphasizing the urgency and specificity of the procurement process. The InstyMed Dispenser System is crucial for enhancing healthcare delivery to veterans, ensuring efficient medication dispensing and management. Interested parties must submit their responses by December 12, 2025, at 10:00 am CST, and can direct inquiries to Contracting Officer Vernise L. Newton at vernise.newton@va.gov or by phone at 414-844-4850.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
    Buyer not available
    The Department of Defense, through the Defense Health Agency, is soliciting quotes for the Pharmacy Uniform Formulary Blanket Purchase Agreement and the Uniform Formulary Additional Discount Program, aimed at establishing an effective pharmacy benefits program for the Military Health System. This procurement involves the evaluation and selection of pharmaceutical agents based on their clinical and cost-effectiveness, with a focus on newly approved drugs that will be reviewed by the Pharmacy and Therapeutics Committee in February 2025. Interested vendors must submit their pricing information, including National Drug Codes (NDCs), by December 19, 2024, and are encouraged to participate in a pre-quotation teleconference on December 4, 2024. For further inquiries, vendors can contact Tracy Banks at tracy.e.banks2.civ@mail.mil or Julia Trang at julia.n.trang.civ@health.mil.
    Q517--FY26: VISN 8 Pharmacy Emergent First Fill Prescription Services
    Buyer not available
    The Department of Veterans Affairs, specifically the Network Contracting Office 8 (NCO 8), is seeking qualified contractors to provide Emergent First Fill Prescription Services for VA beneficiaries within VISN 8, which includes locations in Florida and Puerto Rico. The procurement involves a Firm Fixed Indefinite Delivery Indefinite Quantity contract, covering a base period plus four option years, to deliver 24/7 pharmaceutical benefits management services, including filling new prescriptions and adhering to a specific emergency medication formulary. This service is crucial for ensuring timely access to medications for veterans in emergency situations, with strict requirements for confidentiality and compliance. Quotes are due by December 30, 2025, at 10:00 AM EST, and interested parties should direct inquiries to Contracting Officer Colleen Houser at colleen.houser@va.gov or by phone at 727-201-6880.